Pinto A; Kelleher AD; Cooper DA, 2014, 'AIDS : Clinical Manifestations', in Encyclopaedia of Life Sciences, John Wiley & Sons, http://dx.doi.org/10.1002/9780470015902.a0002237.pub3
Kim KW; Wang X; Adhikari A; Yeang M; Jenkins F; Naing Z; Walker GJ; Foster CSP; Stelzer-Braid S; Deveson I; Craig ME; Tedla N; Bull RA; Martinello M; Pinto AN; Chan R; Turville S; Rawlinson WD; van Hal S, 2022, 'Persistent high-level shedding of cultivable SARS-CoV-2 Delta virus 33 days after onset of COVID-19 in a hospitalized patient with pneumonia', Journal of Medical Virology, vol. 94, pp. 4043 - 4046, http://dx.doi.org/10.1002/jmv.27832
Raubinger S; Lee FJ; Pinto AN, 2022, 'HIV: the changing paradigm', Internal Medicine Journal, vol. 52, pp. 542 - 549, http://dx.doi.org/10.1111/imj.15739
Pinto A; Carrera A; Salem H; Thapa K; Shaik A; Petoumenos K; Cunningham P; Garsia R; Dwyer D; Cooper DA; Kelleher A, 2021, 'Evolution of HIV-1 Surveillance Drug Resistance Mutations over 10 Years in New South Wales, Australia', AIDS Research and Human Retroviruses, vol. 37, pp. 897 - 902, http://dx.doi.org/10.1089/aid.2016.0301
Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Kelleher A; Templeton D; Zablotska-Manos I; Hoy J; McNulty A; Pell C; Grulich A; Bavinton B; Zablotska IB; Grinsztejn B; Cooper DA; Emery S; Wilson D; Koelsch KK; Triffitt K; Doong N; Baker D; Bloch M; Tee BK; Moore R; Roth N; Orth D; Pinto AN, 2021, 'Characteristics of Agreements to have Condomless Anal Intercourse in the Presence of an Undetectable Viral Load Among HIV Serodiscordant Male Couples in Australia, Brazil and Thailand', AIDS and Behavior, vol. 25, pp. 3944 - 3954, http://dx.doi.org/10.1007/s10461-021-03324-7
Patel PG; Keen P; McManus H; Duck T; Callander D; Selvey C; Power C; Gray RT; Knight V; Asselin J; Read P; Johnson K; Bavinton BR; Bowden VJ; Grulich AE; Guy R; Prestage G; Zablotska I; Holden J; Cooper C; Price K; Holt M; de Wit J; Kaldor J; Kelleher A; Wilson D; Brotherton A; Cooper DA; Crooks L; Whittaker B; Madeddu D; Schmidt HM; Telfer B; Boyd M; McGill S; Pinto A; Nigro S; Gordon T; Feeney L; Cunningham P; Mao L; Gray J; O’Dwyer M; Clifton B, 2021, 'Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men', HIV Medicine, vol. 22, pp. 605 - 616, http://dx.doi.org/10.1111/hiv.13102
Baxter JD; Dunn D; Tostevin A; Marvig RL; Bennedbæk M; Cozzi-Lepri A; Sharma S; Kozal MJ; Gompels M; Pinto AN; Lundgren J, 2021, 'Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study', HIV Medicine, vol. 22, pp. 360 - 371, http://dx.doi.org/10.1111/hiv.13038
Di Giallonardo F; Pinto AN; Keen P; Shaik A; Carrera A; Salem H; Selvey C; Nigro SJ; Fraser N; Price K; Holden J; Lee FJ; Dwyer DE; Bavinton BR; Geoghegan JL; Grulich AE; Kelleher AD; Guy R; Prestage G; Zablotska I; Duck T; Cooper C; Holt M; de Wit J; Kaldor J; Wilson D; Brotherton A; Cooper DA; Crooks L; Whittaker B; Callander D; Madeddu D; Schmidt HM; Telfer B; Boyd M; McGill S; Patel P; Power C; Gordon T; Feeney L; Bath K; Mackie B, 2021, 'Subtype-specific differences in transmission cluster dynamics of HIV-1 B and CRF01_AE in New South Wales, Australia', Journal of the International AIDS Society, vol. 24, pp. e25655, http://dx.doi.org/10.1002/jia2.25655
Di Giallonardo F; Pinto AN; Keen P; Shaik A; Carrera A; Salem H; Selvey C; Nigro SJ; Fraser N; Price K; Holden J; Lee FJ; Dwyer DE; Bavinton BR; Grulich AE; Kelleher AD, 2020, 'Increased hiv subtype diversity reflecting demographic changes in the hiv epidemic in new south wales, australia', Viruses, vol. 12, http://dx.doi.org/10.3390/v12121402
Lee G; Robosa R; Fong G; Lee FJ; Lowe P; Pinto AN, 2019, 'Adult cervicofacial nocardiosis in the setting of IL-12/23 blockade', Australasian Journal of Dermatology, vol. 60, pp. 323 - 324, http://dx.doi.org/10.1111/ajd.13046
Sharma S; Schlusser KE; De La Torre P; Tambussi G; Draenert R; Pinto AN; Metcalf JA; Neaton JD; Laeyendecker O, 2019, 'The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection', AIDS, vol. 33, pp. 1335 - 1344, http://dx.doi.org/10.1097/QAD.0000000000002219
Di Giallonardo F; Pinto AN; Keen P; Shaik A; Carrera A; Salem H; Telfer B; Cooper C; Price K; Selvey C; Holden J; Bachmann N; Lee FJ; Dwyer DE; Duchêne S; Holmes EC; Grulich AE; Kelleher AD, 2019, 'Limited sustained local transmission of HIV-1 CRF01_AE in New South Wales, Australia', Viruses, vol. 11, http://dx.doi.org/10.3390/v11050482
Burston J; Robertson M; van Hal S; Pinto AN, 2019, 'Posaconazole and isavuconazole induced hypomagnesaemia', Medical Mycology Case Reports, vol. 23, pp. 29 - 30, http://dx.doi.org/10.1016/j.mmcr.2018.09.007
Hemelaar J; Elangovan R; Yun J; Dickson-Tetteh L; Fleminger I; Kirtley S; Williams B; Gouws-Williams E; Ghys PD; Abimiku AG; Agwale S; Archibald C; Avidor B; Barbás MG; Barre-Sinoussi F; Barugahare B; Belabbes EH; Bertagnolio S; Birx D; Bobkov AF; Brandful J; Bredell H; Brennan CA; Brooks J; Bruckova M; Buonaguro L; Buonaguro F; Buttò S; Buve A; Campbell M; Carr J; Carrera A; Carrillo MG; Celum C; Chaplin B; Charles M; Chatzidimitriou D; Chen Z; Chijiwa K; Cooper D; Cunningham P; Dagnra A; de Gascun CF; Del Amo J; Delgado E; Dietrich U; Dwyer D; Ellenberger D; Ensoli B; Essex M; Gao F; Fleury H; Fonjungo PN; Foulongne V; Gadkari DA; García F; Garsia R; Gershy-Damet GM; Glynn JR; Goodall R; Grossman Z; Lindenmeyer-Guimarães M; Hahn B; Hamers RL; Hamouda O; Handema R; He X; Herbeck J; Ho DD; Holguin A; Hosseinipour M; Hunt G; Ito M; Bel Hadj Kacem MA; Kahle E; Kaleebu PK; Kalish M; Kamarulzaman A; Kang C; Kanki P; Karamov E; Karasi JC; Kayitenkore K; Kelleher T; Kitayaporn D; Kostrikis LG; Kucherer C; Lara C; Leitner T; Liitsola K; Lingappa J; Linka M; Lorenzana de Rivera I; Lukashov V; Maayan S; Mayr L; McCutchan F; Meda N; Menu E; Mhalu F, 2019, 'Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis', The Lancet Infectious Diseases, vol. 19, pp. 143 - 155, http://dx.doi.org/10.1016/S1473-3099(18)30647-9
Pinto AN; Grey P; Shaik A; Cooper DA; Kelleher AD; Petoumenos K, 2018, 'Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality', AIDS Research and Human Retroviruses, vol. 34, pp. 936 - 941, http://dx.doi.org/10.1089/aid.2017.0284
Pinto AN; Hawke K; Castley A; Chibo D; Giallonardo FD; Cooper C; Sawleshwarkar S; Kelleher A; Dwyer DE, 2018, 'HIV-1 subtype diversity, transmitted drug resistance and phylogenetics in Australia', Future Virology, vol. 13, pp. 575 - 584, http://dx.doi.org/10.2217/fvl-2018-0031
Bavinton BR; Pinto AN; Phanuphak N; Grinsztejn B; Prestage GP; Zablotska-Manos IB; Jin F; Fairley CK; Moore RD; Roth N; Bloch M; Pell C; McNulty AM; Baker D; Hoy J; Tee BK; Templeton DJ; Cooper DA; Emery S; Kelleher A; Grulich AE; Bas A; Cooper DA; Wilson D; Koelsch KK; Triffitt K; Doong N; Baker D; Bloch M; Pell C; Hoy J; Orth D, 2018, 'Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study', The Lancet HIV, vol. 5, pp. e438 - e447, http://dx.doi.org/10.1016/S2352-3018(18)30132-2
Schlusser KE; Sharma S; de la Torre P; Tambussi G; Draenert R; Pinto AN; Metcalf JA; German D; Neaton JD; Laeyendecker O, 2018, 'Comparison of self-report to biomarkers of recent hiv infection: Findings from the start trial', AIDS and Behavior, vol. 22, pp. 2277 - 2283, http://dx.doi.org/10.1007/s10461-018-2048-y
Pinto A; Di Giallonardo F; Keen P; Cooper C; Telfer B; Cooper D; Grulich A; Kelleher A, 2018, 'A10 Using the molecular epidemiology of HIV transmission in New South Wales to inform public health response: Assessing the representativeness of linked phylogenetic data', Virus Evolution, vol. 4, http://dx.doi.org/10.1093/ve/vey010.009
Philpot SP; Prestage G; Ellard J; Grulich AE; Bavinton BR, 2018, 'How do gay serodiscordant couples in Sydney, Australia negotiate undetectable viral load for HIV prevention?', AIDS and Behavior, vol. 22, pp. 3981 - 3990, http://dx.doi.org/10.1007/s10461-018-2247-6
Robertson M; Chan R; Mahar A; Othman J; Fong G; Pinto A, 2018, '‘O.I Spy’: Disseminated Talaromyces marneffei infection in an immunocompromised host', Pathology, vol. 50, pp. S52 - S52, http://dx.doi.org/10.1016/j.pathol.2017.12.120
Koelsch KK; Rasmussen TA; Hey-Nguyen WJ; Pearson C; Xu Y; Bailey M; Marks KH; Sasson SC; Taylor MS; Tantau R; Obeid S; Milner B; Morrissey O; Pinto AN; Suzuki K; Busch MP; Keating SM; Kaiser P; Yukl S; Wong JK; Hiener BM; Palmer S; Zaunders J; Post JJ; Chan DJ; Avery S; Milliken ST; Kelleher AD; Lewin SR; Cooper DA, 2017, 'Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals', Journal of Acquired Immune Deficiency Syndromes, vol. 75, pp. 328 - 337, http://dx.doi.org/10.1097/QAI.0000000000001381
Kelly ML; Pinto AN; Suan D; Marriott D; Cooper DA; Pett SL, 2017, 'Managing two decades of visceral leishmaniasis and HIV co-infection: A case report that illustrates the urgent research needs in the field', Sexual Health, vol. 14, pp. 286 - 288, http://dx.doi.org/10.1071/SH16036
Pinto AN; Cooper D, 2014, 'The end of HIV: How do we get there?: Treatment is now the focus of prevention', Medical Journal of Australia, vol. 201, pp. 77 - 78, http://dx.doi.org/10.5694/mja14.00682
Cooper DA; pinto A, 2014, 'Antiretroviral therapy: research, rollout and resistance', Microbiology Australia, vol. 35, pp. 79 - 82, http://dx.doi.org/10.1071/MA14024
Jackson Y; Pinto A; Pett S, 2014, 'Chagas disease in Australia and New Zealand: Risks and needs for public health interventions', Tropical Medicine and International Health, vol. 19, pp. 212 - 218, http://dx.doi.org/10.1111/tmi.12235
Pinto A; Pett S; Jackson Y, 2014, 'Identifying chagas disease in Australia: An emerging challenge for general practitioners', Australian Family Physician, vol. 43, pp. 440 - 442
Pinto AN; Seth R; Zhou F; Tallon J; Dempsey K; Tracy M; Gilbert GL; O'Sullivan MVN, 2013, 'Emergence and control of an outbreak of infections due to Panton-Valentine leukocidin positive, ST22 methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit', Clinical Microbiology and Infection, vol. 19, pp. 620 - 627, http://dx.doi.org/10.1111/j.1469-0691.2012.03987.x
Pinto A, 2012, 'Update in automation: the microbiologist versus the machine', Pathology, vol. 44, pp. S46 - S46, http://dx.doi.org/10.1016/s0031-3025(16)32707-6
Pinto A; Halliday C; Zahra M; van Hal S; Olma T; Maszewska K; Iredell JR; Meyer W; Chen SCA, 2011, 'Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of yeasts is contingent on robust reference spectra', PLoS ONE, vol. 6, http://dx.doi.org/10.1371/journal.pone.0025712
Pinto AN; Phan T; Sala G; Cheong EY; Siarakas S; Gottlieb T, 2011, 'Reusable venesection tourniquets: A potential source of hospital transmission of multiresistant organisms', Medical Journal of Australia, vol. 195, pp. 276 - 279, http://dx.doi.org/10.5694/mja11.10333
Pinto A; Merlino J, 2011, 'CO
Gottlieb T; Phan T; Cheong EYL; Sala G; Siarakas S; Pinto A, 2011, 'Reusable tourniquets. An underestimated means for patient transfer of multi-resistant bacteria', BMC Proceedings, vol. 5, http://dx.doi.org/10.1186/1753-6561-5-s6-p38
Pinto A; Chan R, 2009, 'Lack of allergic cross-reactivity between fluconazole and voriconazole', Antimicrobial Agents and Chemotherapy, vol. 53, pp. 1715 - 1716, http://dx.doi.org/10.1128/AAC.01500-08
Tuch BE; Talbiin M; Casamento FM; Yao M; Georges P; Amaratunga AP; Pinto AN, 2001, 'Role of pancreatic polypeptide as a marker of transplanted insluin-producing fetal pig cells', Cell Transplantation, vol. 10, pp. 285 - 293, https://www.ncbi.nlm.nih.gov/pubmed/11437074
Tuch BE; Wright DC; Martin TR; Keogh G; Deol H; Simpson AM; Roach W; Pinto AN, 1999, 'Fetal Pig Endocrine Cells Develop when Allografted into the Thymus Gland', Transplantation Proceedings, vol. 31, pp. 670 - 670, https://www.ncbi.nlm.nih.gov/pubmed/10083288
Pinto AN, 2015, '"Ten year prevalence of HIV-1 drug resistance mutations in New South Wales, Australia” Posters will be displayed for the duration of the conference (Monday to Wednesday). Late breaker posters are also displayed for the duration of the conference in the Poster Exhibition area. Presentation day: Tuesday, 21 July 2015 Presentation time: 12:30 - 14:30. Poster number: TUPEB281 Location: Exhibition, located in Hall B on the West Exhibition Level', in Ten year prevalence of HIV-1 drug resistance mutations in New South Wales, Australia, IAS 2015, Vancouver, presented at IAS 2015, Vancouver, 19 July 2015 - 22 July 2015
Keen P; Pinto A, 2020, NSW HIV Prevention Partnership Project Evidence Brief on HIV Treatment For the Development of the NSW HIV Strategy 2021-2025
